Journal
AMERICAN JOURNAL OF THE MEDICAL SCIENCES
Volume 341, Issue 6, Pages 439-443Publisher
ELSEVIER SCIENCE INC
DOI: 10.1097/MAJ.0b013e31821a9d7a
Keywords
Pulmonary fibrosis; Familial IPF; Genetics; Telomerase; Surfactant; Mutations
Categories
Funding
- NIH NHBLI [HL85406, HL87738, HL92870]
- ALA
- IPFNet
- Rudy W. Jacobson Endowment for IPF at Vanderbilt University
- Department of Veterans Affairs
Ask authors/readers for more resources
Idiopathic pulmonary fibrosis (IPF) is the most common form of the idiopathic interstitial pneumonias and remains a disease with a poor prognosis. Familial interstitial pneumonia (FIP) occurs when 2 or more individuals from a given family have an idiopathic interstitial pneumonia. FIP cases have been linked to mutations in surfactant protein C, surfactant protein A2, telomerase reverse transcriptase and telomerase RNA component. Together, mutations in these 4 genes likely explain only 15% to 20% of FIP cases and are even less frequent in sporadic IPF. However, dysfunctional aspects of the pathways that are involved with these genes are present in sporadic forms of IPF even in the absence of mutations, suggesting common underlying disease mechanisms. By serving as a resource for identifying the current and future genetic links to disease, FIP families hold great promise in defining IPF pathogenesis, potentially suggesting targets for the development of future therapies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available